June 27th: Upcoming catalyst for the MJ industry FDA will allow a cannabis derived drug called EPIDOLEX by GW pharmaceuticals. It's basically 15% cbd and 5%thc oil to treat Dravets syndrome and the like. Aphria will be essentially be making the exact same thing chemically speaking at their Oil extraction facility producing 25,000KG's of oil.